Bing

Cook noted how much the company was ... when a company has to issue more stock to pay for a merger. Of course, none of those fanciful deals are ever going to happen. But you get my point. No company needs this much cash just for acquisitions.
CNN Money · ByPaul R. La · 2/12/2013
We continue to believe that all events and milestones are priced into Regeneron Pharmaceuticals stock and our estimates include the raised guidance given by management. We maintain a Neutral rating and raise our target to $527 from $495. Regeneron’s ...
Barron's · 8/10/2015
While some of those investors are hoping for a price that’s more than double Ariad’s current stock price — which has hovered between $8 and $9 since late February — Klein said he would guess $12 to $15 a share may be in order. That suggests an ...
The Business Journal · 4/14/2015
Well, as we know there are two types of person in the stock market one is trader and another ... We told our members in facebook private group to buy BioCryst Pharmaceuticals, Inc.(NASDAQ:BCRX) yesterday at $14.30. Now look at the price of the stock ...
Market News Call · 6/19/2015
David W. Hunter founded Hunter Associates, Inc., in July 1992, after 37 years in the securities industry. He started his career in 1954 as a Stockbroker with McKelvy & Company, where he had become a Partner and Manager of the underwriting, research and ...
The Wall Street Transcript · 11/7/2012
In trading on Friday, shares of Illumina Inc (NASDAQ:ILMN) crossed below their 200 day moving average of $198.93, changing hands as low as $197.82 per share. Illumina Inc shares are currently trading up about 0.7% on the day. The chart below shows the …
Market News Video · 8/21/2015
Amgen Inc:Expects FY 2015 Total revenues in the range of $21.1 billion to $21.4 billion and adjusted EPS in the range of $9.55 to $9.80.Previous, FY 2015 expected total revenues in the range of $20.9 billion to $21.3 billion and adjusted EPS in the range ...
Reuters · 7/31/2015
Biotech giant Amgen Inc. said it would lay off up to 2,900 employees and close facilities in Washington state and Colorado, as the Thousand Oaks company moved to reign in expenses and focus on new drugs. Those cuts could amount to nearly 15% of its …
Los Angeles Times · ByStuart Pfeifer · 7/29/2014
Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie …
Schaeffer's Investment Research · ByKaree Venema · 2/25/2015
Trading was light heading into the new year. Market breadth was positive. On the New York Stock Exchange, winners topped losers by over five to one on volume of 1.31 billion shares. On the Nasdaq, advancers beat decliners three to one on volume of 1.61 ...
CNN Money · 12/31/2008

Amgen

Company
Amgen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Locate…
Amgen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world's largest independent biotechnology firm. In 2013, the company's largest selling product lines were Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.
Data from: Wikipedia